RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Executive Officer Abraham Ceesay sold $2.4M of Rapport Therapeutics, Inc.
Sold$2,433,176
$47.25Price
51,499Shares
−10%Stake
What RAPP did after the filing
- The stock from Thu, Aug 13 open, $48.41
- −30.9%
- S&P 500, same days
- −1.2%
Measured over 30 trading days, to the Sep 28 close.
Traded Mon, Aug 10. Filed Wed, Aug 12, 4:35 PM ET, after the close. Returns use the Aug 13 open and the Sep 28 close. Not investment advice.